Phase 2b clinical trials in ulcerative colitis
The Phase 2b study is conducted to evaluate the efficacy and the safety of 3 different doses of ABX464, taken orally once daily by patients with moderate-to-severe ulcerative colitis. On clinicaltrials.gov you can find more information about the study and a list of study centers where the trials are being conducted.
The Phase 2b study is currently open for the recruitment of patients.
Only patients who conclude the “induction phase” of a study have the possibility to roll over into the “maintenance phase”, where long-term effects of the treatment are evaluated. As the Phase 2a induction study in UC is closed for recruitment, no more patients can be enrolled in the corresponding Phase 2a maintenance phase.